- IMGO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Imago BioSciences (IMGO) 8-K3 May 22Imago BioSciences Announces Completion of Enrollment in Phase 2 Clinical Study of Bomedemstat in Essential ThrombocythemiaFinancial data
Company Profile